A. von Graevenitz

1.5k total citations
59 papers, 1.0k citations indexed

About

A. von Graevenitz is a scholar working on Endocrinology, Epidemiology and Infectious Diseases. According to data from OpenAlex, A. von Graevenitz has authored 59 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, 17 papers in Epidemiology and 13 papers in Infectious Diseases. Recurrent topics in A. von Graevenitz's work include Bacterial Identification and Susceptibility Testing (10 papers), Diphtheria, Corynebacterium, and Tetanus (9 papers) and Mycobacterium research and diagnosis (8 papers). A. von Graevenitz is often cited by papers focused on Bacterial Identification and Susceptibility Testing (10 papers), Diphtheria, Corynebacterium, and Tetanus (9 papers) and Mycobacterium research and diagnosis (8 papers). A. von Graevenitz collaborates with scholars based in Switzerland, United States and Germany. A. von Graevenitz's co-authors include Guido Funke, C. Bucher, Eva Grüner, Max Salfinger, O Brändli, James D. Dick, Gerard Osterhout, Allen C. Steere, Martin Altwegg and Peter Vandamme and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

A. von Graevenitz

56 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. von Graevenitz Switzerland 19 413 343 259 160 148 59 1.0k
I. D. Farrell United Kingdom 20 353 0.9× 245 0.7× 286 1.1× 63 0.4× 230 1.6× 52 1.3k
P. Y. Chau Hong Kong 20 234 0.6× 462 1.3× 276 1.1× 100 0.6× 142 1.0× 68 1.3k
M Shayegani United States 22 209 0.5× 323 0.9× 572 2.2× 79 0.5× 238 1.6× 54 1.6k
Alice Friis‐Møller Denmark 22 239 0.6× 226 0.7× 212 0.8× 64 0.4× 320 2.2× 66 1.2k
Joyce de Azavedo Canada 15 235 0.6× 296 0.9× 416 1.6× 45 0.3× 228 1.5× 19 914
Barbara H. Minshew United States 19 740 1.8× 339 1.0× 258 1.0× 111 0.7× 405 2.7× 31 1.7k
R J van Ketel Netherlands 17 334 0.8× 474 1.4× 278 1.1× 61 0.4× 139 0.9× 25 1.2k
P. De Micco France 18 168 0.4× 457 1.3× 348 1.3× 54 0.3× 275 1.9× 54 1.2k
H. Malnick United Kingdom 21 335 0.8× 282 0.8× 128 0.5× 125 0.8× 365 2.5× 40 1.2k
M Jahkola Finland 13 234 0.6× 266 0.8× 333 1.3× 114 0.7× 53 0.4× 25 939

Countries citing papers authored by A. von Graevenitz

Since Specialization
Citations

This map shows the geographic impact of A. von Graevenitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. von Graevenitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. von Graevenitz more than expected).

Fields of papers citing papers by A. von Graevenitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. von Graevenitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. von Graevenitz. The network helps show where A. von Graevenitz may publish in the future.

Co-authorship network of co-authors of A. von Graevenitz

This figure shows the co-authorship network connecting the top 25 collaborators of A. von Graevenitz. A scholar is included among the top collaborators of A. von Graevenitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. von Graevenitz. A. von Graevenitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graevenitz, A. von & Guido Funke. (2013). Turicella otitidis and Corynebacterium auris: 20 years on. Infection. 42(1). 1–4. 16 indexed citations
2.
Grüner, Eva, Milos Opravil, Martin Altwegg, & A. von Graevenitz. (1994). Nontoxigenic Corynebacterium diphtheriae Isolated from Intravenous Drug Users. Clinical Infectious Diseases. 18(1). 94–96. 25 indexed citations
3.
Hüebner, Johannes, et al.. (1993). Shigellemia in AIDS patients: Case report and review of the literature. Infection. 21(2). 122–124. 19 indexed citations
4.
Salfinger, Max, et al.. (1992). Epidemiology and Clinical Significance of Nontuberculous Mycobacteria in Patients Negative for Human Immunodeficiency Virus in Switzerland. Clinical Infectious Diseases. 15(2). 330–345. 81 indexed citations
5.
Graevenitz, A. von, Gerard Osterhout, & James D. Dick. (1991). Grouping of some clinically relevant Gram‐positive rods by automated fatty acid analysis. Apmis. 99(1-6). 147–154. 47 indexed citations
6.
Schär, G, et al.. (1990). Persistent colonization of carbon dioxide incubators withCandida parapsilosis. European Journal of Clinical Microbiology & Infectious Diseases. 9(10). 758–760. 5 indexed citations
7.
Nadal, David, et al.. (1988). Corynebacterium group D2 and urolithiasis in a boy with megacalycosis. Infection. 16(4). 245–247. 16 indexed citations
8.
Graevenitz, A. von, et al.. (1988). RAPIDEC UR, a 2-h miniaturized system for pinpointing uropathogens. Journal of Clinical Microbiology. 26(1). 151–152. 1 indexed citations
9.
Hohl, P., et al.. (1988). Cefetamet pivoxil: Bacteriostatic and bactericidal activity of the free acid against 355 gram-negative rods. Infection. 16(3). 194–198. 5 indexed citations
10.
Graevenitz, A. von, et al.. (1988). Gram stain and culture of morning and 24 h sputum in the diagnosis of bacterial exacerbation of chronic bronchitis: a dogma disputed. European Respiratory Journal. 1(10). 923–928. 5 indexed citations
11.
Graevenitz, A. von, et al.. (1987). Fleroxacin (Ro 23-6240): activity in virtro against 355 enteropathogenic and non-fermentative Gram-negative bacilli and Legionella pneumophila. Journal of Antimicrobial Chemotherapy. 20(3). 373–378. 8 indexed citations
12.
Altwegg, Martin, et al.. (1985). Growth of Aeromonas spp. on cefsulodin-Irgasan-novobiocin agar selective for Yersinia enterocolitica. Journal of Clinical Microbiology. 22(4). 478–480. 21 indexed citations
13.
Graevenitz, A. von & C. Bucher. (1983). Evaluation of differential and selective media for isolation of Aeromonas and Plesiomonas spp. from human feces. Journal of Clinical Microbiology. 17(1). 16–21. 62 indexed citations
14.
Graevenitz, A. von. (1982). Pathogenicity of enterococci outside of urinary tract and blood stream. Journal of Molecular Medicine. 60(14). 696–698. 7 indexed citations
15.
Baltimore, Robert S., et al.. (1982). Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis.. PubMed. 37(6). 547–54. 17 indexed citations
16.
Graevenitz, A. von. (1977). THE ROLE OF OPPORTUNISTIC BACTERIA IN HUMAN DISEASE. Annual Review of Microbiology. 31(1). 447–471. 83 indexed citations
17.
Graevenitz, A. von, et al.. (1975). Should potential sources of hospital-acquired infections be monitored?. Infection. 3(1). 1–5. 5 indexed citations
18.
Graevenitz, A. von, et al.. (1970). The detection of Aeromonas hydrophila in stool specimens.. PubMed. 7(3). 124–7. 57 indexed citations
19.
Friebel, H., et al.. (1958). �ber krankheitsbedingte Ver�nderungen des Arbeitsstoffwechsels bei Ratten. Naunyn-Schmiedeberg s Archives of Pharmacology. 232(3). 522–534.
20.
Friebel, H., et al.. (1958). Chronische Peristonanwendung bei experimenteller Silikose. International Archives of Occupational and Environmental Health. 16(4). 361–374. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026